title: [The 2014 ESC guidelines on the diagnosis and management of hypertrophic cardiomyopathy : what is new?].
abstract: The 2014 European Society of Cardiology (ESC) guidelines on the diagnosis and management of hypertrophic cardiomyopathy (HCM) comprise 133 recommendations with 506 references. In comparison to the last 10-year-old American College of Cardiology Foundation (ACCF)/ESC guidelines new data have been added, such as recent studies on genetics, updated recommendations for family and genetic screening, a special emphasis on red flags in clinical symptomatology and diagnostic features for the identification of non-obstructive variants of HCM, on multimodality non-invasive imaging by echocardiography and cardiac magnetic resonance imaging (MRI) and a HCM risk formula for the assessment of sudden cardiac death within 5 years. Nevertheless, it should not be forgotten that the majority of patients with HCM lead a normal life. This detailed update and the structured recommendations are an excellent summary of the current knowledge on HCM for the cardiomyopathy specialist and also for internists and general physicians.
authors.affiliation: Emer. Direktor der Klinik für Innere Medizin - Kardiologie, Fachbereich Medizinder Philipps-Universität Marburg, privat: Feldbergstr. 45, 35043, Marburg, Deutschland, bermaisch@gmail.com.
authors.forename: B
authors.initials: B
authors.lastname: Maisch
authors.forename: H
authors.initials: H
authors.lastname: Mahrholdt
mesh_terms: D002309:Cardiology / Q000592:standards*; D002312:Cardiomyopathy, Hypertrophic / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy*; D013504:Cardiovascular Surgical Procedures / Q000592:standards*; D003935:Diagnostic Techniques, Cardiovascular / Q000592:standards*; D005060:Europe; D006801:Humans; D018579:Patient Selection